Dementia As a Complication of Schizophrenia
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Vascular Dementia Vascular Dementia
Vascular Dementia Vascular Dementia Other Dementias This information sheet provides an overview of a type of dementia known as vascular dementia. In this information sheet you will find: • An overview of vascular dementia • Types and symptoms of vascular dementia • Risk factors that can put someone at risk of developing vascular dementia • Information on how vascular dementia is diagnosed and treated • Information on how someone living with vascular dementia can maintain their quality of life • Other useful resources What is dementia? Dementia is an overall term for a set of symptoms that is caused by disorders affecting the brain. Someone with dementia may find it difficult to remember things, find the right words, and solve problems, all of which interfere with daily activities. A person with dementia may also experience changes in mood or behaviour. As the dementia progresses, the person will have difficulties completing even basic tasks such as getting dressed and eating. Alzheimer’s disease and vascular dementia are two common types of dementia. It is very common for vascular dementia and Alzheimer’s disease to occur together. This is called “mixed dementia.” What is vascular dementia?1 Vascular dementia is a type of dementia caused by damage to the brain from lack of blood flow or from bleeding in the brain. For our brain to function properly, it needs a constant supply of blood through a network of blood vessels called the brain vascular system. When the blood vessels are blocked, or when they bleed, oxygen and nutrients are prevented from reaching cells in the brain. As a result, the affected cells can die. -
A Patient's Guide to Parkinson's Disease Dementia (PDD)
A Patient’s Guide to Parkinson’s Disease Dementia (PDD) This material is provided by UCSF Weill Institute for Neurosciences as an educational resource for patients. Models for illustrative purposes only. A patient’s guide to Parkinson’s Disease Dementia (PDD) What is dementia? eventually parts of the brain that are important for mental functions such as memory and thinking become injured. Dementia is a general term for any disease that causes a change in memory and/or thinking skills that is severe enough to impair How is age related to PDD? a person’s daily functioning. Symptoms of dementia vary from Both PD and PDD are more common with increasing age. Most person to person and may affect one’s ability to remember things, people with PD start having movement symptoms between ages concentrate, plan and organize, communicate or find one’s way 50 and 85, although some people have shown signs earlier. Up to around, among other possible symptoms. There are many causes 80% of people with PD eventually develop dementia. The average of dementia and Parkinson’s disease can be one of them. Not at all time from onset of movement problems to development people with Parkinson’s disease develop dementia. of dementia is about 10 years. What is Parkinson’s disease dementia? What happens in PDD? Parkinson’s disease dementia (PDD) is changes in thinking and People with PDD may have trouble focusing, remembering things, behavior in someone with a diagnosis of Parkinson’s disease (PD). or making sound judgments. They may develop depression, anxiety PD is an illness characterized by gradually progressive problems or irritability. -
Mild Cognitive Impairment Or Dementia
What To Know When You Have Mild Cognitive Impairment or Dementia People who are told they have mild cognitive impairment (MCI) experience symptoms that are similar to dementia, but aren’t as serious. People with MCI have changes in memory or thinking typically poorer than would be expected for someone their age, but the changes don’t interfere with daily activities. It should be noted that people with MCI have a higher risk of developing dementia, but not all will. Dementia is an umbrella term to describe symptoms that are severe enough to interfere with daily activities. The most common cause of dementia in older adults is Alzheimer’s disease. Other causes include Lewy body dementia, vascular dementia and Frontotemporal diseases. A diagnosis of Alzheimer’s disease or a related disorder doesn’t change who you are and it doesn’t mean you need to stop doing things you find meaningful. It does mean that over time you might have to do them in a different way or have some assistance. The disease does not affect the entire brain all at once. Many areas of the brain are not affected, or are affected much later. Important Messages Dementia can affect memory, We All Should Know thinking, communication and doing everyday tasks. Dementia is not a natural part of aging. It’s possible to live well with dementia. Dementia is caused by diseases of the brain and will There is more to a person affect each person differently. than the dementia. Ways to Work With Mild Cognitive Impairment or Dementia 1 6 Stop multi-tasking. -
When the Mind Falters: Cognitive Losses in Dementia
T L C When the Mind Falters: Cognitive Losses in Dementia by L Joel Streim, MD T Associate Professor of Psychiatry C Director, Geriatric Psychiatry Fellowship Program University of Pennsylvania VISN 4 Mental Illness Research Education and Clinical Center Philadelphia VA Medical Center Delaware Valley Geriatric Education Center The goal of this module is to teach direct staff about the syndrome of dementia and its clinical effects on residents. It focuses on the ways that the symptoms of dementia affect persons’ functional ability and behavior. We begin with an overview of the symptoms of cognitive impairment. We continue with a description of the causes, epidemiology, and clinical course (stages) of dementia. We then turn to a closer look at the specific areas of cognitive impairment, and examine how deficits in different areas of cognitive function can interfere with the person’s daily functioning, causing disability. The accompanying videotape illustrates these principles, using the example of a nursing home resident whose cognitive impairment interferes in various ways with her eating behavior and ability to feed herself. 1 T L Objectives C At the end of this module you should be able to: Describe the stages of dementia Distinguish among specific cognitive impairments from dementia L Link specific cognitive impairments with the T disabilities they cause C Give examples of cognitive impairments and disabilities Describe what to do when there is an acute change in cognitive or functional status Delaware Valley Geriatric Education Center At the end of this module you should be able to • Describe the stages of dementia. These are early, middle and late, and we discuss them in more detail. -
The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1
The Clinical Presentation of Psychotic Disorders Bob Boland MD Slide 1 Psychotic Disorders Slide 2 As with all the disorders, it is preferable to pick Archetype one “archetypal” disorder for the category of • Schizophrenia disorder, understand it well, and then know the others as they compare. For the psychotic disorders, the diagnosis we will concentrate on will be Schizophrenia. Slide 3 A good way to organize discussions of Phenomenology phenomenology is by using the same structure • The mental status exam as the mental status examination. – Appearance –Mood – Thought – Cognition – Judgment and Insight Clinical Presentation of Psychotic Disorders. Slide 4 Motor disturbances include disorders of Appearance mobility, activity and volition. Catatonic – Motor disturbances • Catatonia stupor is a state in which patients are •Stereotypy • Mannerisms immobile, mute, yet conscious. They exhibit – Behavioral problems •Hygiene waxy flexibility, or assumption of bizarre • Social functioning – “Soft signs” postures as most dramatic example. Catatonic excitement is uncontrolled and aimless motor activity. It is important to differentiate from substance-induced movement disorders, such as extrapyramidal symptoms and tardive dyskinesia. Slide 5 Disorders of behavior may involve Appearance deterioration of social functioning-- social • Behavioral Problems • Social functioning withdrawal, self neglect, neglect of • Other – Ex. Neuro soft signs environment (deterioration of housing, etc.), or socially inappropriate behaviors (talking to themselves in -
Schizophrenia
Schizophrenia The upcoming fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) makes several key changes to the category of schizophrenia and highlights for future study an area that could be critical for early detection of this often debilitating condition. Changes to the Diagnosis Schizophrenia is characterized by delusions, hallucinations, disorganized speech and behavior, and other symptoms that cause social or occupational dysfunction. For a diagnosis, symptoms must have been present for six months and include at least one month of active symptoms. DSM-5 raises the symptom threshold, requiring that an individual exhibit at least two of the specified symptoms. (In the manual’s previous editions, that threshold was one.) Additionally, the diagnostic criteria no longer identify subtypes. Subtypes had been defined by the predominant symptom at the time of evaluation. But these were not helpful to clinicians because patients’ symptoms often changed from one subtype to another and presented overlapping subtype symptoms, which blurred distinc- tions among the five subtypes and decreased their validity. Some of the subtypes are now specifiers to help provide further detail in diagnosis. For example, catatonia (marked by motor immobility and stupor) will be used as a specifier for schizophrenia and other psychotic conditions such as schizoaffec- tive disorder. This specifier can also be used in other disorder areas such as bipolar disorders and major depressive disorder. Area for Further Study Attenuated psychosis syndrome is included in Section III of the new manual; conditions listed there require further research before their consideration as formal disorders. This potential category would identify a person who does not have a full-blown psychotic disorder but exhibits minor versions of relevant symptoms. -
APA Patient and Caregiver Guide: Antipsychotic Medications to Treat
PATIENT AND CAREGIVER GUIDE: Antipsychotic Medications to Treat Agitation or Psychosis in Adults with Dementia OVERVIEW Dementia—a group of symptoms that includes memory loss, confusion, and trouble with problem-solving that is severe enough to disrupt daily life—affects over 5 million Americans, particularly those age 65 and older. Many people living with dementia can develop agitation or psychosis. These symptoms may come and go or last for longer periods of time. They can be stressful and possibly dangerous for the people living with dementia and their caregivers. If these symptoms are not treated, families may have a harder time providing care and the person living with dementia may ultimately need long-term care. Treating agitation and psychosis can improve the quality of life for people living with dementia and provide some relief to their caregivers. This guide provides information about the causes of agitation and psychosis in adults living with dementia and available treatment options. It can help patients and families begin the discussion with their doctor to make an informed decision about appropriate treatment. The patient and caregiver guide is based on the practice guideline the American Psychiatric Association (APA) published in 2016 for psychiatrists and other health professionals. The complete guideline, The Use of Antipsychotics to Treat Agitation or Psychosis in Patients with Dementia, is available from APA Publishing, along with more information about how it was developed. KEY TERMS Dementia Agitation A group of symptoms, including memory loss, confusion, A state of excessive physical movement, verbal and trouble with problem solving or finding words, that aggression, or physical aggression to oneself or others is severe enough to disrupt daily life due to a decline in that is associated with emotional distress. -
Alzheimer's Disease
Evaluation of Cognitive Decline in a Person with Intellectual and Developmental Disabilities Changing US Population Demographics Aging and Intellectual and Developmental Disabilities ●In 2002, an estimated 641,000 adults with IDD were older than 60. ●In 2002 about 75% of all older adults with IDD were in the 40-60 year old age range. ●The number of adults with IDD age 60 years and older is projected to nearly double from 641,860 in 2000 to 1.2 million by 2030 due to increasing life expectancy and the aging of the baby boomer generation Carter & Jancar, 1983, Janicki, Dalton, Henderson, & Davidson, 1999 . Currently estimated life expectancy of a . 25% of persons with Down 1-year-old child with DS is between 43 syndrome are still alive at 65 and 55 years years Curr Gerontol Geriatr Res. 2012; 2012: 412-536. Rubin & Crocker,2006; Yang Rasmussen & Friedman, 2002 Expected Physical Changes of Aging ●Osteopenia/Osteoporosis - normal aging-related bone loss ●Sarcopenia - progressive loss of muscle mass ●Presbyopia: the lens of the eye becomes stiffer and less flexible – affecting the ability to focus on close objects (accommodation) ●Presbycusis – aging related change in the ability to detect higher pitches – more noticeable in those age 50+ ●Gustation (i.e. the sense of taste) decrements become more noticeable beyond 60+ ●Olfaction (i.e. the sense of smell) decrements become more noticeable after age 70+ ●Somatosensory System - Reduction in sensitivity to pain, touch, temperature, proprioception ●Vestibular – Reduction in balance and coordination -
Association Between Schizophrenia Polygenic Score and Psychotic Symptoms In
bioRxiv preprint doi: https://doi.org/10.1101/528802; this version posted January 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Association between schizophrenia polygenic score and psychotic symptoms in Alzheimer’s disease: meta-analysis of 11 cohort studies. Byron Creese1,2*, Evangelos Vassos3*, Sverre Bergh2,4,5*, Lavinia Athanasiu6,7, Iskandar Johar8,2, Arvid Rongve9,10,,2, Ingrid Tøndel Medbøen5,11, Miguel Vasconcelos Da Silva1,8,2, Eivind Aakhus4, Fred Andersen12, Francesco Bettella6,7 , Anne Braekhus5,11,13, Srdjan Djurovic10,14, Giulia Paroni16, Petroula Proitsi17, Ingvild Saltvedt18,19, Davide Seripa16, Eystein Stordal20,21, Tormod Fladby22,23, Dag Aarsland2,8,24, Ole A. Andreassen6,7, Clive Ballard1,2*, Geir Selbaek4,5,25*, on behalf of the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative** 1. University of Exeter Medical School, Exeter, UK 2. Norwegian, Exeter and King's College Consortium for Genetics of Neuropsychiatric Symptoms in Dementia 3. Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London 4. Research centre of Age-related Functional Decline and Disease, Innlandet Hospital Trust, Pb 68, Ottestad 2312, Norway 5. Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway 6. NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 7. NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway 8. Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London 9. -
Psychotic Symptoms in Post Traumatic Stress Disorder: a Case Illustration and Literature Review
CASE REPORT SA Psych Rev 2003;6: 21-24 Psychotic symptoms in post traumatic stress disorder: a case illustration and literature review Adekola O Alao, Laura Leso, Mantosh J Dewan, Erika B Johnson Department of Psychiatry, State University of New York, Syracuse, NY, USA ABSTRACT Posttraumatic stress disorder (PTSD) is a condition being increasingly recognized. The diagnosis is based on the re-experiencing of a traumatic event. There have been reports of the presence of psychotic symptoms in some cases of PTSD. This may represent in- creased severity or a different diagnostic clinical entity. It has also been suggested that psychotic symptoms may be over-represented in the Hispanic population. In this manuscript, we describe a case to illustrate this relationship and we review the current literature on the relationship of psychotic symptoms among PTSD patients. The implications regarding diagnosis, treatment, and prognosis are discussed. Keywords: Psychosis; PTSD; Trauma; Hallucinations; Delusions; Posttraumatic stress disorder. INTRODUCTION the best of our knowledge is the first report of psychotic symp- Posttraumatic stress disorder (PTSD) is a psychiatric illness for- toms in a non-veteran adult with PTSD. mally recognized with the publication of the third edition of the Diagnostic and Statistical Manual of the American Psychiatric CASE ILLUSTRATION Association in 1980.1 Re-experiencing of traumatic events as A 37 year-old gentleman was admitted to a state university hos- recurrent unpleasant images, nightmares, and intrusive feelings pital inpatient setting after alerting his wife of his suicidal is a core characteristic of PTSD.2 Most PTSD research has oc- thoughts and intent to slit his throat with a kitchen knife. -
A Postmortem Neuropathologic Study of 100 Cases
ORIGINAL ARTICLE Alzheimer Disease and Related Neurodegenerative Diseases in Elderly Patients With Schizophrenia A Postmortem Neuropathologic Study of 100 Cases Dushyant P. Purohit, MD; Daniel P. Perl, MD; Vahram Haroutunian, PhD; Peter Powchik, MD; Michael Davidson, MD; Kenneth L. Davis, MD Background: Clinical studies suggest that severe cognitive im- nile plaques or neurofibrillary tangles was not different pairment is common among elderly patients with schizophrenia in the group with schizophrenia compared with the age- who reside in long-stay psychiatric institutions; however, previ- matched controls or the group with nonschizophrenic ous autopsy-based neuropathologic investigations have provided psychiatric disorders. The higher Clinical Dementia Rat- conflicting results about the occurrence of Alzheimer disease (AD) ing Scale scores lacked correlation with neuropatho- in elderly patients with schizophrenia. We report the results of a logic evidence of dementing disorders. In the 87 cases comprehensive neuropathologic study performed to identify AD lacking a neuropathologic diagnosis of AD or other de- and other dementing neurodegenerative diseases in elderly pa- menting disorders, the mean (±SD) Clinical Dementia Rat- tients with schizophrenia. ing Scale score was 2.21 (±1.14), with 43 of the cases scor- ing 3 or higher (indicating severe, profound, or terminal Methods: A neuropathologic examination was per- cognitive impairment). formed on 100 consecutive autopsy brain specimens of patients aged 52 to 101 years (mean, 76.5 years). A cog- Conclusions: This study provides evidence that el- nitive assessment of these cases was also done by em- derly patients with schizophrenia are not inordinately ploying the Clinical Dementia Rating Scale. For com- prone to the development of AD or to increased senile parison, we included 47 patients with nonschizophrenic plaques or neurofibrillary tangle formation in the brain. -
The ICD-10 Classification of Mental and Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines
ICD-10 ThelCD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines | World Health Organization I Geneva I 1992 Reprinted 1993, 1994, 1995, 1998, 2000, 2002, 2004 WHO Library Cataloguing in Publication Data The ICD-10 classification of mental and behavioural disorders : clinical descriptions and diagnostic guidelines. 1.Mental disorders — classification 2.Mental disorders — diagnosis ISBN 92 4 154422 8 (NLM Classification: WM 15) © World Health Organization 1992 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications — whether for sale or for noncommercial distribution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.